ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000660.1|Albaflavenone_1 # 1 # 1086 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.648	BGC0000660.1|Albaflavenone_1 	1	1086	+	Loose	700	26.9498	cfr(D)	27.87	3005021	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	GTGCATGCTTTCCCACACGGCACCACAGCGACACCGACCGCGATCGCAGTACCGCCATCGCTCCGTCTCCCGGTGATCGAGGCGGCATTTCCCCGGCAACTGCACCCGTATTGGCCGAAGCTCCAGGAGACAACCCGGACCTGGCTGCTCGAAAAGCGGCTCATGCCGGCGGACAAGGTCGAGGAATATGCCGACGGTCTGTGCTACACGGACCTCATGGCGGGCTACTACCTGGGCGCCCCCGACGAGGTCCTGCAGGCGATAGCGGACTACAGCGCGTGGTTCTTCGTCTGGGACGACCGTCACGACCGTGACATCGTCCACGGCCGGGCCGGTGCCTGGCGGCGACTGCGCGGCCTGCTGCACACGGCACTGGACTCACCCGGGGACCACCTGCACCACGAGGACACGCTGGTGGCCGGGTTCGCCGACAGTGTGCGGCGGCTCTACGCCTTCCTGCCGGCCACCTGGAACGCCCGGTTCGCCCGGCACTTCCACACGGTGATCGAGGCGTACGACCGTGAATTCCACAACCGCACGCGCGGAATCGTGCCCGGCGTGGAGGAGTACCTCGAACTGCGCCGGCTCACGTTCGCGCACTGGATCTGGACCGACCTGCTGGAGCCGAGTTCGGGCTGCGAACTCCCCGACGCCGTACGGAAACACCCGGCATATCGCCGGGCGGCGTTGCTGAGTCAGGAATTCGCCGCCTGGTACAACGACCTCTGCTCACTGCCAAAGGAAATAGCGGGAGACGAGGTCCACAATCTTGGCATCAGTCTCATCACCCACCATTCACTCACCCTGGAAGAAGCCATCGGAGAAGTCCGGCGTCGTGTCGAGGAATGCATCACGGAATTCCTCGCCGTCGAGCGGGACGCCTTACGGTTCGCCGACGAACTCGCCGACGGAACCGTACGCGGAAAGGAACTGAGCGGCGCCGTGCGGGCCAACGTCGGCAATATGCGGAACTGGTTCAGTTCCGTCTACTGGTTCCACCACGAGTCCGGCCGGTACATGGTCGACAGCTGGGACGACCGGTCCACGCCCCCGTACGTCAACAACGAAGCGGCAGGTGAGAAATGA	VHAFPHGTTATPTAIAVPPSLRLPVIEAAFPRQLHPYWPKLQETTRTWLLEKRLMPADKVEEYADGLCYTDLMAGYYLGAPDEVLQAIADYSAWFFVWDDRHDRDIVHGRAGAWRRLRGLLHTALDSPGDHLHHEDTLVAGFADSVRRLYAFLPATWNARFARHFHTVIEAYDREFHNRTRGIVPGVEEYLELRRLTFAHWIWTDLLEPSSGCELPDAVRKHPAYRRAALLSQEFAAWYNDLCSLPKEIAGDEVHNLGISLITHHSLTLEEAIGEVRRRVEECITEFLAVERDALRFADELADGTVRGKELSGAVRANVGNMRNWFSSVYWFHHESGRYMVDSWDDRSTPPYVNNEAAGEK	MLQKQLTKYQQIEKVLKECQQPNYRMKQILHCIFKEKKTDFNEMSVLPKNLRDTLTTEIGTSLLTVEPLIEQKSQQVRKVLFNLSGDNRIETVNMTYQAGWESFCISSQCGCNLGCQFCATGKIGLRKNLTAEEITDQVLYFLLKGHQIDSISFMGMGEPLANPHFFEALDIFMNPDMFQLSPRRLSVSTIGVIPKIKRLTAEYPQVHLTFSLHSPFDEERSQLMPINKSFPLLKVMDTLDEHIKVTSKKVYIAYILLPDVNDSLTHAVALADLLRSRYKKGKLYHVNLIRYNPTFDAPRTFKQVDEKQVKLFYQTLISKGINVTIRSQFGIEIDAACGQLYGNYEIKNKKTIQVND	101.12	gnl|BL_ORD_ID|2813|hsp_num:0	3763		
BGC0000660.1|Albaflavenone_2 # 1083 # 2468 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.688	BGC0000660.1|Albaflavenone_2 	1083	2468	+	Loose	250	26.9498	arr-4	43.33	3002849	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin ADP-ribosyltransferase (Arr)	ATGACCGTCGAGTCCGTCAACCCCGAAACCCGCGCACCCGCGGCACCGGGAGCACCGGAGCTGCGCGAGCCGCCCGTCGCGGGCGGTGGCGTTCCGCTGCTCGGCCACGGCTGGCGGCTGGCCCGCGACCCGCTGGCCTTCATGTCCCAGCTGCGCGACCACGGCGACGTCGTGCGCATCAAGCTCGGCCCGAAGACCGTCTACGCCGTCACGAACCCCGAGCTGACCGGCGCCCTCGCCCTGAACCCCGACTACCACATCGCCGGTCCGCTGTGGGAGTCGCTGGAGGGCCTGCTCGGCAAGGAGGGCGTGGCGACCGCCAACGGCCCGCTCCACCGCCGCCAGCGGCGCACCATCCAGCCGGCGTTCCGGCTCGACGCCATCCCCGCCTACGGGCCGATCATGGAGGAGGAGGCGCACGCGCTCACCGAGCGCTGGCAGCCGGGGAAGACCGTCGACGCCACCTCGGAGTCCTTCCGGGTCGCCGTGCGCGTCGCGGCCCGCTGCCTGCTGCGCGGGCAGTACATGGACGAGCGGGCCGAGCGGCTCTGCGTCGCGCTCGCCACCGTCTTCCGGGGCATGTACCGGCGGATGGTGGTCCCGCTCGGGCCGCTGTACCGGCTGCCGCTTCCGGCCAACCGCCGATTCAACGACGCGTTGGCCGATCTGCACCTGCTGGTCGACGAGATCATCGCCGAGCGCCGTGCATCCGGTCAAAAGCCGGACGATTTGCTCACGGCATTGCTGGAGGCGAAGGACGACAATGGCGACCCGATCGGGGAACAGGAGATCCACGACCAGGTGGTCGCGATACTCACCCCGGGCAGTGAAACCATCGCGTCCACGATCATGTGGTTGCTCCAGGCACTTGCCGACCATCCGGAACATGCCGACCGCATACGCGACGAAGTCGAAGCGGTCACCGGCGGACGTCCCGTGGCATTCGAGGACGTCCGGAAGCTCAGGCACACCGGCAATGTCATCGTGGAGGCCATGCGTTTGCGTCCCGCCGTATGGGTATTGACCCGGCGCGCGGTGGCCGAGAGCGAACTCGGTGGCTATCGCATTCCGGCCGGTGCGGACATCATCTACAGTCCGTACGCAATCCAACGCGATCCGAAGTCGTACGACGACAACCTGGAGTTCGATCCCGACCGGTGGCTACCGGAACGCGCGGCGAATGTGCCGAAATACGCCATGAAGCCGTTCAGCGCGGGCAAGCGGAAGTGCCCCAGTGACCACTTTTCGATGGCCCAGCTCACGCTGATCACGGCCGCGCTCGCCACGAAGTACCGCTTCGAACAGGTGGCGGGCTCGAACGACGCGGTCCGGGTCGGCATCACGCTGCGTCCGCACGACCTGCTGGTCAGGCCCGTGGCGCGGTGA	MTVESVNPETRAPAAPGAPELREPPVAGGGVPLLGHGWRLARDPLAFMSQLRDHGDVVRIKLGPKTVYAVTNPELTGALALNPDYHIAGPLWESLEGLLGKEGVATANGPLHRRQRRTIQPAFRLDAIPAYGPIMEEEAHALTERWQPGKTVDATSESFRVAVRVAARCLLRGQYMDERAERLCVALATVFRGMYRRMVVPLGPLYRLPLPANRRFNDALADLHLLVDEIIAERRASGQKPDDLLTALLEAKDDNGDPIGEQEIHDQVVAILTPGSETIASTIMWLLQALADHPEHADRIRDEVEAVTGGRPVAFEDVRKLRHTGNVIVEAMRLRPAVWVLTRRAVAESELGGYRIPAGADIIYSPYAIQRDPKSYDDNLEFDPDRWLPERAANVPKYAMKPFSAGKRKCPSDHFSMAQLTLITAALATKYRFEQVAGSNDAVRVGITLRPHDLLVRPVAR	MTNDWIPTSHDNCSQVAGPFYHGTKAKLTVGDLLSPGHPSHFEQGRKLKHIYFAALMEPAIWGAELAMSLSSLEGRGHIYIVEPLGPFEDDPNLTNKKFPGNPTKSYRTTEPLRIVGIVEDWQGHSPEVLQGMLASLEDLQRRGLAIIED	307.33	gnl|BL_ORD_ID|159|hsp_num:0	173		
